FDA Accepts Camurus’ Resubmitted NDA for CAM2029 in Acromegaly Endocrinology Advisor 14:36 Tue, 21 Jul
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA PR Newswire (Press Release) 06:26 Fri, 17 Jul